Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon, whose practice encompasses the upper gastrointestinal tract. She has led a group of diverse BIDMC faculty in oncology research, education and care for GI, endocrine, breast, as well as melanomas and sarcomas, and other malignancies.
Dr. Tseng has published more than 100 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care, an important BMC and BUSM mission. She has collaborated with the Massachusetts Department of Public Health to assess the impact of factors including insurance, disparities and health care reform on cancer diagnosis, treatment and prevention. She was the Founding Director of SOAR (Surgical Outcomes Analysis & Research) at UMass in 2007, a research initiative to improve treatment strategies for a broad range of surgical conditions and to develop tools to assess and reduce risk. At BIDMC, she and her co-leaders have led the continued development of SOAR as a health services and outcomes research group.
Dr. Tseng is also a dedicated educator of medical students and residents who has mentored numerous trainees throughout her research career.
Boston University School of Medicine
Boston Medical Center
BU-BMC Cancer Center
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 177 results.
Fayanju OM, Haukoos JS, Tseng JF. CHEERS Reporting Guidelines for Economic Evaluations. JAMA Surg. 2021 Apr 07. PMID: 33825848
Stewart JH, Butler PD, Tseng JF, Kennard AC, Mellinger JD, Buyske J. Acknowledgment, Reflection, and Action: The American Board of Surgery Leans into Antiracism. Ann Surg. 2021 04 01; 273(4):619-622. PMID: 33351484
Aly S, de Geus SWL, Carter CO, Sachs TE, Hess DT, Tseng JF, Pernar LIM. Impact of fellow compared to resident assistance on outcomes of minimally invasive surgery. Surg Endosc. 2021 Mar 24.View Related Profiles. PMID: 33763745
de Geus SW, Woods AP, Papageorge MV, Zheng J, Ng SC, McAneny D, Sachs TE, Tseng JF. Combined Hepatopancreaticobiliary Volume and Hepatectomy Outcomes in Hepatocellular Carcinoma Patients at Low-Volume Liver Centers. J Am Coll Surg. 2021 Feb 25.View Related Profiles. PMID: 33640522
Papageorge MV, de Geus SWL, Woods AP, Ng SC, Drake FT, Cassidy MR, McAneny DB, Tseng JF, Sachs TE. Undertreatment of Gallbladder Cancer: A Nationwide Analysis. Ann Surg Oncol. 2021 Feb 10.View Related Profiles. PMID: 33566241
Sachs TE, Tseng JF. Landmark Series in Pancreatic Tumors: Anastomotic Techniques and Route of Reconstruction. Ann Surg Oncol. 2021 Apr; 28(4):2227-2234.View Related Profiles. PMID: 33550501
Gomes C, Tivnan P, McAneny D, Tseng JF, Tkacz J, Sachs TE. Choledochal Cyst or Benign Biliary Dilation: Is Resection Always Necessary? J Gastrointest Surg. 2021 Jan 22.View Related Profiles. PMID: 33483915
Poulson MR, Blanco BA, Geary AD, Kenzik KM, McAneny DB, Tseng JF, Sachs TE. The role of racial segregation in treatment and outcomes among patients with hepatocellular carcinoma. HPB (Oxford). 2021 Jan 19.View Related Profiles. PMID: 33536151
de Geus SWL, Hachey KJ, Nudel JD, Ng SC, McAneny DB, Davies JD, Tseng JF, Sachs TE. Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers. Ann Surg. 2020 Dec 02.View Related Profiles. PMID: 33273352
Blanco BA, Poulson M, Kenzik KM, McAneny DB, Tseng JF, Sachs TE. The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality. Ann Surg Oncol. 2020 Nov 01.View Related Profiles. PMID: 33135144
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.